Neuropsychiatric disorders in chronic hepatitis C patients after receiving interferon or direct-acting antivirals: a nationwide cohort study

Background: Data on the neuropsychological outcomes after receiving direct-acting antivirals (DAAs) among chronic hepatitis C (CHC) patients have not been well-documented. Aim: This study aimed to evaluate the difference in incidence of neuropsychological disorders (NPDs) after treatment completion...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yu, Chen, Chung-Yu, Yu, Hsien-Chung, Lin, Pei-Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394649/
https://www.ncbi.nlm.nih.gov/pubmed/37538181
http://dx.doi.org/10.3389/fphar.2023.1191843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394649/
https://www.ncbi.nlm.nih.gov/pubmed/37538181
http://dx.doi.org/10.3389/fphar.2023.1191843

Ejemplares similares